(1)
Glycated Haemogloin, Fasting Plasma Glucose, Plasminogen Activator Inhibitor Type-1, and Soluble Thrombomodulin Levels in Patients With Type 2 Diabetes Mellitus. NJPS 2021, 36 (2), 159-164. https://doi.org/10.54548/njps.v36i2.3.